Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

I G Miller

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Genes & Molecular Sequences

Viral Genes

Disorders

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
25
Gradoville, Lyn
23
Heston, Lee
17
Shedd, Duane
16
Sun, R
15
Grogan, E
12
Andiman, Warren
11
El-Guindy, Ayman
10
Lin, SF
5
Chang, Pey-Jium
5
Nikiforow, Sarah
5
Rigsby, MO
4
Jenson, Hal
4
Delecluse, Henri-Jacques
4
Ragoczy, Tobias
3
Ye, Jianjiang

Sign-in to see all Coauthors

Publications

TOP 3
Park Richard; Heston Lee; Shedd Duane; Delecluse Henri-Jacques; Miller George
Mutations of amino acids in the DNA-recognition domain of Epstein-Barr virus ZEBRA protein alter its sub-nuclear localization and affect formation of replication compartments.
Chang Pey-Jium; Shedd Duane; Miller George
A mobile functional region of Kaposi's sarcoma-associated herpesvirus ORF50 protein independently regulates DNA binding and protein abundance.
Countryman Jill K; Gradoville Lyndle; Miller George
Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of I G Miller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Park Richard; Heston Lee; Shedd Duane; Delecluse Henri-Jacques; Miller George
Mutations of amino acids in the DNA-recognition domain of Epstein-Barr virus ZEBRA protein alter its sub-nuclear localization and affect formation of replication compartments.
Virology 2008;382(2):145-62.
2008: Chang Pey-Jium; Shedd Duane; Miller George
A mobile functional region of Kaposi's sarcoma-associated herpesvirus ORF50 protein independently regulates DNA binding and protein abundance.
Journal of virology 2008;82(19):9700-16.
2008: Countryman Jill K; Gradoville Lyndle; Miller George
Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.
Journal of virology 2008;82(10):4706-19.
2008: Bhaduri-McIntosh Sumita; Rotenberg Marisa J; Gardner Benjamin; Robert Marie; Miller George
Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines.
Blood 2008;111(3):1334-43.
2007: Ye Jianjiang; Gradoville Lyndle; Daigle Derek; Miller George
De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Journal of virology 2007;81(17):9279-91.
2007: El-Guindy Ayman; Heston Lee; Delecluse Henri-Jacques; Miller George
Phosphoacceptor site S173 in the regulatory domain of Epstein-Barr Virus ZEBRA protein is required for lytic DNA replication but not for activation of viral early genes.
Journal of virology 2007;81(7):3303-16.
2007: Bhaduri-McIntosh Sumita; Landry Marie L; Nikiforow Sarah; Rotenberg Marisa; El-Guindy Ayman; Miller George
Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
The Journal of infectious diseases 2007;195(4):483-92.
2007: Miller George; El-Guindy Ayman; Countryman Jill; Ye Jianjiang; Gradoville Lyn
Lytic cycle switches of oncogenic human gammaherpesviruses.
Advances in cancer research 2007;97():81-109.
2006: DiMaio Daniel; Miller George
Thirty years into the genomics era: tumor viruses led the way.
The Yale journal of biology and medicine 2006;79(3-4):179-85.
2006: Bhaduri-McIntosh Sumita; Miller George
Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBV-seropositive individuals.
Journal of virological methods 2006;137(1):103-14.
2006: Heston Lee; El-Guindy Ayman; Countryman Jill; Dela Cruz Charles; Delecluse Henri-Jacques; Miller George
Amino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication.
Journal of virology 2006;80(18):9115-33.
2006: El-Guindy Ayman S; Paek So Yeon; Countryman Jill; Miller George
Identification of constitutive phosphorylation sites on the Epstein-Barr virus ZEBRA protein.
The Journal of biological chemistry 2006;281(6):3085-95.
2005: Chen Lee-Wen; Chang Pey-Jium; Delecluse Henri-Jacques; Miller George
Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus.
Journal of virology 2005;79(15):9635-50.
2005: Chang Pey-Jium; Shedd Duane; Miller George
Two subclasses of Kaposi's sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are deficient in binding to DNA.
Journal of virology 2005;79(14):8750-63.
2005: Ye Jianjiang; Shedd Duane; Miller George
An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate.
Journal of virology 2005;79(3):1397-408.
2004: Chang Pey-Jium; Miller George
Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein.
Journal of virology 2004;78(19):10657-73.
2004: El-Guindy Ayman S; Miller George
Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.
Journal of virology 2004;78(14):7634-44.
2004: Dela Cruz Charles S; Lee Yoomi; Viswanathan Srinivas R; El-Guindy Ayman S; Gerlach Jennifer; Nikiforow Sarah; Shedd Duane; Gradoville Lyn; Miller George
N-linked glycosylation is required for optimal function of Kaposi's sarcoma herpesvirus-encoded, but not cellular, interleukin 6.
The Journal of experimental medicine 2004;199(4):503-14.
2003: Nikiforow Sarah; Bottomly Kim; Miller George; Münz Christian
Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein-Barr virus-induced B-cell proliferation.
Journal of virology 2003;77(22):12088-104.
2002: Miller I George; El-Guindy Ayman
Regulation of Epstein-Barr virus lytic cycle activation in malignant and nonmalignant disease.
Journal of the National Cancer Institute 2002;94(23):1733-5.
2002: El-Guindy Ayman S; Heston Lee; Endo Yoshimi; Cho Myung-Sam; Miller George
Disruption of Epstein-Barr virus latency in the absence of phosphorylation of ZEBRA by protein kinase C.
Journal of virology 2002;76(22):11199-208.
2002: Gradoville Lyndle; Kwa David; El-Guindy Ayman; Miller George
Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Journal of virology 2002;76(11):5612-26.
2002: Chang Pey-Jium; Shedd Duane; Gradoville Lyn; Cho Myung-Sam; Chen Lee-Wen; Chang Jimmy; Miller George
Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements.
Journal of virology 2002;76(7):3168-78.
2001: Ragoczy T; Miller G
Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.
Journal of virology 2001;75(11):5240-51.
2001: Almuneef M; Nimjee S; Khoshnood K; Miller G; Rigsby M O
Prevalence of antibodies to human herpesvirus 8 (HHV-8) in Saudi Arabian patients with and without renal failure.
Transplantation 2001;71(8):1120-4.
2001: Nikiforow S; Bottomly K; Miller G
CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.
Journal of virology 2001;75(8):3740-52.
2000: Gradoville L; Gerlach J; Grogan E; Shedd D; Nikiforow S; Metroka C; Miller G
Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line.
Journal of virology 2000;74(13):6207-12.
2000: Aquino-De Jesus M J; Anders C; Miller G; Sleasman J W; Goodenow M M; Andiman W A
Genetically and epidemiologically related "non-syncytium-inducing" isolates of HIV-1 display heterogeneous growth patterns in macrophages.
Journal of medical virology 2000;61(2):171-80.
2000: Cinquina C C; Grogan E; Sun R; Lin S F; Beardsley G P; Miller G
Dihydrofolate reductase from Kaposi's sarcoma-associated herpesvirus.
Virology 2000;268(1):201-17.
1999: Ragoczy T; Miller G
Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes.
Journal of virology 1999;73(12):9858-66.
1999: Francis A; Ragoczy T; Gradoville L; Heston L; El-Guindy A; Endo Y; Miller G
Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator.
Journal of virology 1999;73(6):4543-51.
1999: Staskus K A; Sun R; Miller G; Racz P; Jaslowski A; Metroka C; Brett-Smith H; Haase A T
Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Journal of virology 1999;73(5):4181-7.
1999: Sun R; Lin S F; Staskus K; Gradoville L; Grogan E; Haase A; Miller G
Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression.
Journal of virology 1999;73(3):2232-42.
1998: Serio T R; Cahill N; Prout M E; Miller G
A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle.
Journal of virology 1998;72(10):8338-43.
1998: Ragoczy T; Heston L; Miller G
The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes.
Journal of virology 1998;72(10):7978-84.
1998: Sun R; Lin S F; Gradoville L; Yuan Y; Zhu F; Miller G
A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(18):10866-71.
1998: Angeloni A; Heston L; Uccini S; Sirianni M C; Cottoni F; Masala M V; Cerimele D; Lin S F; Sun R; Rigsby M; Faggioni A; Miller G
High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia.
The Journal of infectious diseases 1998;177(6):1715-8.
1998: Qunibi W; Al-Furayh O; Almeshari K; Lin S F; Sun R; Heston L; Ross D; Rigsby M; Miller G
Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia.
Transplantation 1998;65(4):583-5.
1997: Serio T R; Kolman J L; Miller G
Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis.
Journal of virology 1997;71(11):8726-34.
1997: Spain T A; Sun R; Miller G
The locus of Epstein-Barr virus terminal repeat processing is bound with enhanced affinity by Sp1 and Sp3.
Virology 1997;237(1):137-47.
1997: Sun R; Spain T A; Lin S F; Miller G
Sp1 binds to the precise locus of end processing within the terminal repeats of Epstein-Barr virus DNA.
Journal of virology 1997;71(8):6136-43.
1997: Spain T A; Sun R; Gradzka M; Lin S F; Craft J; Miller G
The transcriptional activator Sp1, a novel autoantigen.
Arthritis and rheumatism 1997;40(6):1085-95.
1997: Grossberg S E; Kushnaryov V M; Cashdollar L W; Raisch K P; Miller G; Sun H Y
A human B-lymphoblastoid cell line constitutively producing Epstein-Barr herpesvirus and JHK retrovirus.
Research in virology 1997;148(3):191-206.
1997: Lin S F; Sun R; Heston L; Gradoville L; Shedd D; Haglund K; Rigsby M; Miller G
Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.
Journal of virology 1997;71(4):3069-76.
1997: Francis A L; Gradoville L; Miller G
Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency.
Journal of virology 1997;71(4):3054-61.
1997: Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov V M; Grossberg S; Chang Y
Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.
Journal of virology 1997;71(1):314-24.
1996: Serio T R; Angeloni A; Kolman J L; Gradoville L; Sun R; Katz D A; Van Grunsven W; Middeldorp J; Miller G
Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21).
Journal of virology 1996;70(11):8047-54.
1996: Sun R; Lin S F; Gradoville L; Miller G
Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11883-8.
1996: Miller G; Rigsby M O; Heston L; Grogan E; Sun R; Metroka C; Levy J A; Gao S J; Chang Y; Moore P
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.
The New England journal of medicine 1996;334(20):1292-7.
1996: Bal A K; Miller G; Viscarello R; Andiman W A
Syncytium-inhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of human immunodeficiency virus type 1.
The Pediatric infectious disease journal 1996;15(4):315-20.
1996: Kolman J L; Taylor N; Gradoville L; Countryman J; Miller G
Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.
Journal of virology 1996;70(3):1493-504.
1995: Shedd D; Angeloni A; Niederman J; Miller G
Detection of human serum antibodies to the BFRF3 Epstein-Barr virus capsid component by means of a DNA-binding assay.
The Journal of infectious diseases 1995;172(5):1367-70.
1995: Sun R; Grogan E; Shedd D; Bykovsky A F; Kushnaryov V M; Grossberg S E; Miller G
Transmissible retrovirus in Epstein-Barr virus-producer B95-8 cells.
Virology 1995;209(2):374-83.
1994: Countryman J K; Heston L; Gradoville L; Himmelfarb H; Serdy S; Miller G
Activation of the Epstein-Barr virus BMRF1 and BZLF1 promoters by ZEBRA in Saccharomyces cerevisiae.
Journal of virology 1994;68(11):7628-33.
1994: Sun R; Spain T A; Lin S F; Miller G
Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNA.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(18):8646-50.
1993: Miller G; Himmelfarb H; Heston L; Countryman J; Gradoville L; Baumann R; Chi T; Carey M
Comparing regions of the Epstein-Barr virus ZEBRA protein which function as transcriptional activating sequences in Saccharomyces cerevisiae and in B cells.
Journal of virology 1993;67(12):7472-81.
1993: Kolman J L; Taylor N; Marshak D R; Miller G
Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(21):10115-9.
1993: Baumann R; Grogan E; Ptashne M; Miller G
Changing Epstein-Barr viral ZEBRA protein into a more powerful activator enhances its capacity to disrupt latency.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(10):4436-40.
1993: Ikeda M K; Andiman W A; Mezger J L; Shapiro E D; Miller G
Quantitative leukoviremia and immune complex-dissociated antigenemia as predictors of infection status in children born to mothers infected with human immunodeficiency virus type 1.
The Journal of pediatrics 1993;122(4):524-31.
1992: Pedneault L; Katz B Z; Miller G
Detection of Epstein-Barr virus in the brain by the polymerase chain reaction.
Annals of neurology 1992;32(2):184-92.
1992: Kolman J L; Kolman C J; Miller G
Marked variation in the size of genomic plasmids among members of a family of related Epstein-Barr viruses.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(16):7772-6.
1992: Carey M; Kolman J; Katz D A; Gradoville L; Barberis L; Miller G
Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.
Journal of virology 1992;66(8):4803-13.
1992: Jankelevich S; Kolman J L; Bodnar J W; Miller G
A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain.
The EMBO journal 1992;11(3):1165-76.
1992: Katz D A; Baumann R P; Sun R; Kolman J L; Taylor N; Miller G
Viral proteins associated with the Epstein-Barr virus transactivator, ZEBRA.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(1):378-82.
1991: Taylor N; Flemington E; Kolman J L; Baumann R P; Speck S H; Miller G
ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.
Journal of virology 1991;65(8):4033-41.
1991: Brenner T J; Dahl K E; Olson B; Miller G; Andiman W A
Relation between HIV-1 syncytium inhibition antibodies and clinical outcome in children.
Lancet 1991;337(8748):1001-5.
1991: Orlowski R; Miller G
Single-stranded structures are present within plasmids containing the Epstein-Barr virus latent origin of replication.
Journal of virology 1991;65(2):677-86.
1991: Miller G
Molecular approaches to epidemiologic evaluation of viruses as risk factors for patients who have chronic fatigue syndrome.
Reviews of infectious diseases 1991;13 Suppl 1():S119-22.
1990: Gradoville L; Grogan E; Taylor N; Miller G
Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.
Virology 1990;178(2):345-54.
1990: Andiman W A; Simpson B J; Olson B; Dember L; Silva T J; Miller G
Rate of transmission of human immunodeficiency virus type 1 infection from mother to child and short-term outcome of neonatal infection. Results of a prospective cohort study.
American journal of diseases of children (1960) 1990;144(7):758-66.
1990: Orlowski R; Polvino-Bodnar M; Hearing J; Miller G
Inhibition of specific binding of EBNA 1 to DNA by murine monoclonal and certain human polyclonal antibodies.
Virology 1990;176(2):638-42.
1990: Miller G
The switch between latency and replication of Epstein-Barr virus.
The Journal of infectious diseases 1990;161(5):833-44.
1990: Dahl K E; Burrage T; Jones F; Miller G
Persistent nonproductive infection of Epstein-Barr virus-transformed human B lymphocytes by human immunodeficiency virus type 1.
Journal of virology 1990;64(4):1771-83.
1990: Orlowski R; Miller G
Topological effects of EBNA 1 on oriP.
Advances in experimental medicine and biology 1990;278():115-24.
1989: Katz B Z; Raab-Traub N; Miller G
Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases.
The Journal of infectious diseases 1989;160(4):589-98.
1989: Taylor N; Countryman J; Rooney C; Katz D; Miller G
Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses.
Journal of virology 1989;63(4):1721-8.
1989: Rooney C; Howe J G; Speck S H; Miller G
Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
Journal of virology 1989;63(4):1531-9.
1989: Miller G
The switch between EBV latency and replication.
The Yale journal of biology and medicine 1989;62(2):205-13.
1988: Rooney C; Taylor N; Countryman J; Jenson H; Kolman J; Miller G
Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9801-5.
1988: Jenson H B; Miller G
Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency.
Virology 1988;165(2):549-64.
1988: Katz B Z; Niederman J C; Olson B A; Miller G
Fragment length polymorphisms among independent isolates of Epstein-Barr virus from immunocompromised and normal hosts.
The Journal of infectious diseases 1988;157(2):299-308.
1987: Countryman J; Jenson H; Seibl R; Wolf H; Miller G
Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.
Journal of virology 1987;61(12):3672-9.
1987: Miller G; Martin K; Katz B Z; Andiman W A
AIDS and antibodies to human immunodeficiency virus (HIV) in children and their families: clinical experience at Yale-New Haven Hospital.
The Yale journal of biology and medicine 1987;60(6):527-35.
1987: Miller G; Grogan E; Rowe D; Rooney C; Heston L; Eastman R; Andiman W; Niederman J; Lenoir G; Henle W
Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection.
The Journal of infectious diseases 1987;156(1):26-35.
1987: Miller G; Katz B Z; Niederman J C
Some recent developments in the molecular epidemiology of Epstein-Barr virus infections.
The Yale journal of biology and medicine 1987;60(4):307-19.
1987: Dahl K; Martin K; Miller G
Differences among human immunodeficiency virus strains in their capacities to induce cytolysis or persistent infection of a lymphoblastoid cell line immortalized by Epstein-Barr virus.
Journal of virology 1987;61(5):1602-8.
1987: Jenson H B; Farrell P J; Miller G
Sequences of the Epstein-Barr Virus (EBV) large internal repeat form the center of a 16-kilobase-pair palindrome of EBV (P3HR-1) heterogeneous DNA.
Journal of virology 1987;61(5):1495-506.
1987: Grogan E; Jenson H; Countryman J; Heston L; Gradoville L; Miller G
Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(5):1332-6.
1987: Rowe D T; Farrell P J; Miller G
Novel nuclear antigens recognized by human sera in lymphocytes latently infected by Epstein-Barr virus.
Virology 1987;156(1):153-62.
1987: Martin K; Katz B Z; Miller G
AIDS and antibodies to human immunodeficiency virus (HIV) in children and their families.
The Journal of infectious diseases 1987;155(1):54-63.
1986: Niederman J C; Miller G
Kinetics of the antibody response to BamHI-K nuclear antigen in uncomplicated infectious mononucleosis.
The Journal of infectious diseases 1986;154(2):346-9.
1986: Rosenberg N L; Hochberg F H; Miller G; Kleinschmidt-DeMasters B K
Primary central nervous system lymphoma related to Epstein-Barr virus in a patient with acquired immune deficiency syndrome.
Annals of neurology 1986;20(1):98-102.
1986: Luka J; Miller G; Jörnvall H; Pearson G R
Characterization of the restricted component of Epstein-Barr virus early antigens as a cytoplasmic filamentous protein.
Journal of virology 1986;58(3):748-56.
1986: Jenson H B; Rabson M S; Miller G
Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA.
Journal of virology 1986;58(2):475-86.
1986: Polvino-Bodnar M; Shedd D; Miller G
Deletion mutants that affect expression of Epstein-Barr virus nuclear antigen in COS-1 cells after gene transfer with simian virus 40 vectors containing portions of the BamHI K fragment.
Journal of virology 1986;58(2):324-30.
1986: Schooley R T; Carey R W; Miller G; Henle W; Eastman R; Mark E J; Kenyon K; Wheeler E O; Rubin R H
Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy.
Annals of internal medicine 1986;104(5):636-43.
1986: Katz B Z; Andiman W A; Eastman R; Martin K; Miller G
Infection with two genotypes of Epstein-Barr virus in an infant with AIDS and lymphoma of the central nervous system.
The Journal of infectious diseases 1986;153(3):601-4.
1986: Miller G
Animal model for Epstein-Barr lymphoma.
Nature 1986;319(6055):626.
1985: Andiman W A; Eastman R; Martin K; Katz B Z; Rubinstein A; Pitt J; Pahwa S; Miller G
Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS.
Lancet 1985;2(8469-70):1390-3.
1985: Rowe D; Heston L; Metlay J; Miller G
Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(21):7429-33.
1985: Ho M; Miller G; Atchison R W; Breinig M K; Dummer J S; Andiman W; Starzl T E; Eastman R; Griffith B P; Hardesty R L
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.
The Journal of infectious diseases 1985;152(5):876-86.
1985: Miller G; Sugden B
An identification of a transforming region of Epstein-Barr viral DNA cannot be confirmed.
Virology 1985;143(2):478-84.
1985: Countryman J; Miller G
Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(12):4085-9.
1985: Weigel R; Miller G
Latent and viral replicative transcription in vivo from the BamHI K fragment of Epstein-Barr virus DNA.
Journal of virology 1985;54(2):501-8.
1985: Miller G; Heston L; Countryman J
P3HR-1 Epstein-Barr virus with heterogeneous DNA is an independent replicon maintained by cell-to-cell spread.
Journal of virology 1985;54(1):45-52.
1985: Miller G; Grogan E; Fischer D K; Niederman J C; Schooley R T; Henle W; Lenoir G; Liu C R
Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer.
The New England journal of medicine 1985;312(12):750-5.
1985: Schubach W H; Miller G; Thomas E D
Epstein-Barr virus genomes are restricted to secondary neoplastic cells following bone marrow transplantation.
Blood 1985;65(3):535-8.
1985: Weigel R; Fischer D K; Heston L; Miller G
Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication.
Journal of virology 1985;53(1):254-9.
1984: Brown N; Smith D; Miller G; Niederman J; Liu C; Robinson J
Infectious mononucleosis: a polyclonal B cell transformation in vivo.
The Journal of infectious diseases 1984;150(4):517-22.
1984: Martin P J; Shulman H M; Schubach W H; Hansen J A; Fefer A; Miller G; Thomas E D
Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody.
Annals of internal medicine 1984;101(3):310-5.
1984: Robert M F; Shedd D; Weigel R J; Fischer D K; Miller G
Expression in COS-1 cells of Epstein-Barr virus nuclear antigen from a complete gene and a deleted gene.
Journal of virology 1984;50(3):822-31.
1984: Burrage T G; Andiman W A; Katz B Z; Miller G
Virus-like rods in a lymphoid line from an infant with AIDS.
The New England journal of medicine 1984;310(22):1460-1.
1984: Miller G
Epstein-Barr virus--immortalization and replication.
The New England journal of medicine 1984;310(19):1255-6.
1984: Miller G; Rabson M; Heston L
Epstein-Barr virus with heterogeneous DNA disrupts latency.
Journal of virology 1984;50(1):174-82.
1984: Fischer D K; Robert M F; Shedd D; Summers W P; Robinson J E; Wolak J; Stefano J E; Miller G
Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(1):43-7.
1984: Miller G
Regions of the EBV genome involved in latency and lymphocyte immortalization.
Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progrès en virologie médicale 1984;30():107-28.
1983: Grogan E A; Summers W P; Dowling S; Shedd D; Gradoville L; Miller G
Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(24):7650-3.
1983: Andiman W; Gradoville L; Heston L; Neydorff R; Savage M E; Kitchingman G; Shedd D; Miller G
Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases.
The Journal of infectious diseases 1983;148(6):967-77.
1983: Rabson M; Heston L; Miller G
Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(9):2762-6.
1983: Weigel R; Miller G
Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters.
Virology 1983;125(2):287-98.
1982: Rabson M; Gradoville L; Heston L; Miller G
Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.
Journal of virology 1982;44(3):834-44.
1982: Summers W P; Grogan E A; Shedd D; Robert M; Liu C R; Miller G
Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4-megadalton cloned fragment of Epstein-Barr virus DNA.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(18):5688-92.
1982: Miller G; Heston L; Hoffman G
Neutralization of lymphocyte immortalization by different strains of Epstein-Barr virus with a murine monoclonal antibody.
Infection and immunity 1982;37(3):1028-31.
1982: Schubach W H; Hackman R; Neiman P E; Miller G; Thomas E D
A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia.
Blood 1982;60(1):180-7.
1982: Miller G
Immortalization of human lymphocytes by Epstein-Barr virus.
The Yale journal of biology and medicine 1982;55(3-4):305-10.
1982: Heston L; Rabson M; Brown N; Miller G
New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma.
Nature 1982;295(5845):160-3.
1982: Andiman W A; Miller G
Persistent infection with adenovirus types 5 and 6 in lymphoid cells from humans and woolly monkeys.
The Journal of infectious diseases 1982;145(1):83-8.
1982: Brown N A; Miller G
Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.
Journal of immunology (Baltimore, Md. : 1950) 1982;128(1):24-9.
1981: Grogan E; Miller G; Moore T; Robinson J; Wright J
Resistance of neonatal human lymphoid cells to infection by herpes simplex virus overcome by aging cells in culture.
The Journal of infectious diseases 1981;144(6):547-56.
1981: Grogan E; Miller G; Henle W; Rabson M; Shedd D; Niederman J C
Expression of Epstein-Barr viral early antigen in monolayer tissue cultures after transfection with viral DNA and DNA fragments.
Journal of virology 1981;40(3):861-9.
1981: Fischer D K; Miller G; Gradoville L; Heston L; Westrate M W; Maris W; Wright J; Brandsma J; Summers W C
Genome of a mononucleosis Epstein-Barr virus contains DNA fragments previously regarded to be unique to Burkitt's lymphoma isolates.
Cell 1981;24(2):543-53.
1981: Anvret M; Miller G
Copy number and location of Epstein-Barr Viral genomes in neonatal human lymphocytes transformed after separation by size and treatment with mitogens.
Virology 1981;111(1):47-55.
1981: Miller G; Grogan E; Heston L; Robinson J; Smith D
Epstein-Barr viral DNA: infectivity for human placental cells.
Science (New York, N.Y.) 1981;212(4493):452-5.
1981: Lerner M R; Andrews N C; Miller G; Steitz J A
Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(2):805-9.
1981: Miller G; Fischer D K
Beneficial effects of human viruses.
The Yale journal of biology and medicine 1981;54(1):57-63.
1980: Brandsma J; Miller G
Nucleic acid spot hybridization: rapid quantitative screening of lymphoid cell lines for Epstein-Barr viral DNA.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(11):6851-5.
1980: Robinson J E; Brown N; Andiman W; Halliday K; Francke U; Robert M F; Andersson-Anvret M; Horstmann D; Miller G
Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus.
The New England journal of medicine 1980;302(23):1293-7.
1979: Morgan D G; Niederman J C; Miller G; Smith H W; Dowaliby J M
Site of Epstein-Barr virus replication in the oropharynx.
Lancet 1979;2(8153):1154-7.
1979: Robinson J; Frank A; Henderson E; Schweitzer J; Miller G
Surface markers and size of lymphocytes in human umbilical cord blood stimulated into deoxyribonucleic acid synthesis by Epstein-Barr Virus.
Infection and immunity 1979;26(1):225-31.
1979: Coope D; Heston L; Brandsma J; Miller G
Cross-neutralization of infectious mononucleosis and Burkitt lymphoma strains of Epstein-Barr virus with hyperimmune rabbit antisera.
Journal of immunology (Baltimore, Md. : 1950) 1979;123(1):232-8.
1979: Wilson G; Miller G
Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants.
Virology 1979;95(2):351-8.
1979: Miller G; Wertheim P; Wilson G; Robinson J; Geelen J L; van der Noordaa J; van der Eb A J
Transfection of human lymphoblastoid cells with herpes simplex viral DNA.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(2):949-53.
1979: Enck R E; Betts R F; Brown M R; Miller G
Viral serology (hepatitis B virus, cytomegalovirus, Epstein-Barr virus) and abnormal liver function tests in transfused patients with hereditary hemorrhagic diseases.
Transfusion 1979;19(1):32-8.
1978: Andiman W A; Miller G
Properties of Epstein-Barr virus transformed woolly monkey lymphoblastoid cell lines.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1978;157(3):489-93.
1978: Henderson E; Heston L; Grogan E; Miller G
Radiobiological inactivation of Epstein-Barr virus.
Journal of virology 1978;25(1):51-9.
1978: Robinson J E; Andiman W A; Henderson E; Miller G
Differences in expression of surface marker characteristics on Epstein-Barr virus-transformed human and simian lymphoid cell lines.
Primates in medicine 1978;10():149-55.
1977: Henderson E; Robinson J; Frank A; Miller G
Epstein-Barr virus: transformation of lymphocytes separated by size or exposed to bromodeoxyuridine and light.
Virology 1977;82(1):196-205.
1977: Miller G; Shope T; Coope D; Waters L; Pagano J; Bornkamn G; Henle W
Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses.
The Journal of experimental medicine 1977;145(4):948-67.
1977: Robinson J E; Andiman W A; Henderson E; Miller G
Host-determined differences in expression of surface marker characteristics on human and simian lymphoblastoid cell lines transformed by Epstein-Barr virus.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(2):749-53.
1977: Henderson E; Miller G; Robinson J; Heston L
Efficiency of transformation of lymphocytes by Epstein-Barr virus.
Virology 1977;76(1):152-63.
1976: Miller G; Coope D; Niederman J; Pagano J
Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.
Journal of virology 1976;18(3):1071-80.
1976: Niederman J C; Miller G; Pearson H A; Pagano J S; Dowaliby J M
Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx.
The New England journal of medicine 1976;294(25):1355-9.
1976: Miller G
Some aspects of the biologic behavior of Epstein-Barr virus.
Advances in pathobiology 1976;(5):25-41.
1976: Frank A; Andiman W A; Miller G
Epstein-Barr virus and nonhuman primates: natural and experimental infection.
Advances in cancer research 1976;23():171-201.
1975: Lipman M; Andrews L; Niederman J; Miller G
Direct visualization of enveloped Epstein-Barr Herpesvirus in throat washing with leukocyte-transforming activity.
The Journal of infectious diseases 1975;132(5):520-3.
1975: Miller G; Robinson J; Heston L; Lipman M
Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection and interference.
IARC scientific publications 1975;(11 Pt 1):395-408.
1975: Miller G
Epstein-Barr herpesvirus and infectious mononucleosis.
Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progrès en virologie médicale 1975;20():84-112.
1975: Shope T C; Miller G
EB virus: malignant lymphoma in cottontop marmosets following inoculation and recovery of the virus from cells of an experimental tumor maintained in organ culture.
Bibliotheca haematologica 1975;(40):375-83.
1975: Miller G; Robinson J; Heston L
Immortalizing and nonimmortalizing laboratory strains of Epstein-Barr Virus.
Cold Spring Harbor symposia on quantitative biology 1975;39 Pt 2():773-81.
1974: Miller G; Robinson J; Heston L; Lipman M
Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.
Proceedings of the National Academy of Sciences of the United States of America 1974;71(10):4006-10.
1974: Miller G
The oncogenicity of Epstein-Barr virus.
The Journal of infectious diseases 1974;130(2):187-205.
1974: Strauch B; Andrews L L; Siegel N; Miller G
Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs.
Lancet 1974;1(7851):234-7.
1974: Miller G; Coope D
Epstein-Barr viral nuclear antigen (EBNA) in tumor cell imprints of experimental lymphoma of marmosets.
Transactions of the Association of American Physicians 1974;87():205-18.
1974: Miller G; Heston L
Expression of Epstein-Barr viral capsid, complement fixing, and nuclear antigens in stationary and exponential phase cultures.
The Yale journal of biology and medicine 1974;47(2):123-35.
1973: Miller G; Lipman M
Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus.
The Journal of experimental medicine 1973;138(6):1398-412.
1973: Shope T; Dechairo D; Miller G
Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus.
Proceedings of the National Academy of Sciences of the United States of America 1973;70(9):2487-91.
1973: Miller G; Niederman J C; Andrews L L
Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis.
The New England journal of medicine 1973;288(5):229-32.
1973: Shope T; Miller G
Epstein-Barr virus. Heterophile responses in squirrel monkeys inoculated with virus-transformed autologous leukocytes.
The Journal of experimental medicine 1973;137(1):140-7.
1973: Miller G; Lipman M
Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
Proceedings of the National Academy of Sciences of the United States of America 1973;70(1):190-4.
1972: Miller G; Shope T; Heston L; O'Brien R; Schwartz A; Pearson H
Prospective study of Epstein-Barr virus infections in acute lymphoblastic leukemia of childhood.
The Journal of pediatrics 1972;80(6):932-7.
1972: Shope T C; Klein-Robbenhaar J; Miller G
Fatal encephalitis due to Herpesvirus hominis: use of intact brain cells for isolation of virus.
The Journal of infectious diseases 1972;125(5):542-4.
1972: Miller G; Niederman J C; Stitt D A
Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines.
The Journal of infectious diseases 1972;125(4):403-6.
1972: Miller G; Shope T; Lisco H; Stitt D; Lipman M
Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes.
Proceedings of the National Academy of Sciences of the United States of America 1972;69(2):383-7.
1971: Blacklow N R; Watson B K; Miller G; Jacobson B M
Mononucleosis with heterophil antibodies and EB virus infection. Acquisition by an elderly patient in hospital.
The American journal of medicine 1971;51(4):549-52.
1971: Miller G; Emmons J; Stitt D
Susceptibility of human lymphoblastoid cell lines to a cytopathic effect induced by an arginine-utilizing mycoplasma strain.
The Journal of infectious diseases 1971;124(3):322-6.
1971: Miller G; Lisco H; Kohn H I; Stitt D; Enders J F
Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1971;137(4):1459-65.
1971: Miller G
Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man.
The Yale journal of biology and medicine 1971;43(6):358-84.
1970: Miller M H; Stitt D; Miller G
Epstein-Barr viral antigen in single cell clones of two human leukocytic lines.
Journal of virology 1970;6(5):699-701.
1968: Miller G; Enders J F
Vaccinia virus replication and cytopathic effect in cultures in phytohemagglutinin-treated human peripheral blood leukocytes.
Journal of virology 1968;2(8):787-92.

Sign-in to see more